Cardiovascular effects of omega-3 fatty acids: Hope or hype?
- Authors
- Jo, Sang-Ho; Han, Seung Hwan; Kim, Sang-Hyun; Eckel, R.H.; Koh, Kwang Kon
- Issue Date
- Apr-2021
- Publisher
- Elsevier Ireland Ltd
- Keywords
- Atherosclerosis; Omega-3 fatty acids; Residual cardiovascular risk
- Citation
- Atherosclerosis, v.322, pp.15 - 23
- Journal Title
- Atherosclerosis
- Volume
- 322
- Start Page
- 15
- End Page
- 23
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80875
- DOI
- 10.1016/j.atherosclerosis.2021.02.014
- ISSN
- 0021-9150
- Abstract
- Omega-3 fatty acids have emerged as a new option for controlling the residual risk for cardiovascular disease (CVD) in the statin era after a clinical trial (REDUCE-IT) reported positive results with icosapent ethyl (IPE) in patients receiving maximally tolerated statin therapy. However, another trial which used high dose eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) combination (STRENGTH) has failed. Together, these results raise clinically important questions. Are effects of omega-3 fatty acids neutral or beneficial in patients on statin therapy, or perhaps even harmful? The current contradictory results could be attributed to different types of omega-3 fatty acids (only EPA or combination of EPA + DHA), doses (higher vs. lower dose) of omega-3 fatty acids or different comparators (corn oil or mineral oil), as well as the underlying severity of the CVD risk or use of statins. Together with these issues, we will discuss different biological and clinical effects of various types of omega-3 fatty acids and then interpret different results of past and current clinical studies and propose practical suggestions, which could be applied in patient management. © 2021
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80875)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.